News Releases

The following news releases are issued by GlaxoSmithKline Inc. In addition to these resources, you may also find GlaxoSmithKline global news of interest.

November 10, 2011

GlaxoSmithKline Inc. Launches $50 Million Life Sciences Innovation Fund in Canada

November 02, 2011

The OmniPod^TM Insulin Management System, the World's First Tubeless Insulin Pump, is Now Available for Canadians with Type 1 Diabetes

October 20, 2011

GlaxoSmithKline celebrates 11 years as one of the 50 Best Employers in Canada

October 19, 2011

Survey Finds Canadian Women Want to Prevent Cervical Cancer - But Most Aren't Taking Steps to Do So

September 29, 2011

New Diabetes Research Chair - Prime Suspect: Fatty Foods

September 28, 2011

CQDM explore competition announces its first award winners

July 12, 2011

Health Canada Approves BENLYSTA™ The First New Treatment for Systemic Lupus Erythematosus in Almost 50 Years

June 15, 2011

Province, University of Manitoba, GlaxoSmithKline Inc. Establish Endowed Research Chair to Study Infectious Disease

June 9, 2011

Investing In Innovation To Create 70 New Jobs And Protect 300 Jobs

May 31, 2011

MaRS Innovation and GlaxoSmithKline Announce Strategic Partnership to Accelerate Translational Research in Health Sciences

March 28, 2011

GSK publishes 2010 Corporate Responsibility Report

March 2, 2011

Insulet Corporation and GlaxoSmithKline Inc. Sign Distribution Agreement for the OmniPod Insulin Management System in Canada

February 16, 2011

CQDM welcomes two additional Pharma members, Boehringer Ingelheim and GlaxoSmithKline Inc., and launches its Explore Program to drive innovation

January 26, 2011

Breakthrough on Cystic Fibrosis one step closer as new research alliance formed

January 25, 2011

New therapy option approved in Canada for chronic immune thrombocytopenic purpura (ITP) Revolade^TM (eltrombopag) is the first oral, once-a-day platelet generator approved by Health Canada for patients with ITP